Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.49 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 4/20 | 0.39 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.38 |
| ▸ | GRK6 | P43250 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | OXTR | P30559 | 1/20 | 0.36 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30103087 | 1.00 | KDM1A (0.49) | KDM1APHF8GRM5FYNALOX5AP | |
| SCHEMBL24785816 | 0.89 | NPC1 (0.47) | FYNALOX5APFEN1TDO2PDGFRB | |
| SCHEMBL30103021 | 0.89 | NPC1 (0.47) | FYNALOX5APFEN1TDO2PDGFRB | |
| SCHEMBL30103062 | 0.86 | KDM1A (0.49) | KDM1APHF8GRM5FYNALOX5AP | |
| SCHEMBL24785826 | 0.86 | KDM1A (0.49) | KDM1APHF8GRM5FYNALOX5AP | |
| SCHEMBL24784615 | 0.83 | GRM5 (0.46) | KDM1AGRM5FYNGRK6PAX8 | |
| SCHEMBL30103063 | 0.81 | KDM1A (0.55) | KDM1AFYNROCK2 | |
| SCHEMBL24785040 | 0.81 | KDM1A (0.55) | KDM1AFYNROCK2 | |
| SCHEMBL30103043 | 0.81 | KDM1A (0.55) | KDM1AFYNROCK2 | |
| SCHEMBL24785814 | 0.75 | ALDH1A1 (0.47) | ALOX5APFEN1TDO2PDGFRBPDGFRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022257960-A1 | BICYCLIC COMPOUND FOR THE TREATMENT OF EP2 AND EP4 RECEPTOR-MEDIATED DISEASES | 武汉人福创新药物研发中心有限公司 | 2022-12-15 | — | — | WO | disclosed |